Radewonuk J - Search Results

1

IgE isotype switch and IgE production are enhanced in IL-21-deficient but not IFN-gamma-deficient mice in a Th2-biased response.

Shang XZ, Ma KY, Radewonuk J, Li J, Song XY, Griswold DE, Emmell E, Li L. Shang XZ, et al. Among authors: radewonuk j. Cell Immunol. 2006 Jun;241(2):66-74. doi: 10.1016/j.cellimm.2006.07.011. Epub 2006 Sep 18. Cell Immunol. 2006. PMID: 16979605

2

Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.

Li J, Bracht M, Shang X, Radewonuk J, Emmell E, Griswold DE, Li L. Li J, et al. Among authors: radewonuk j. Cell Immunol. 2006 Jun;241(2):75-84. doi: 10.1016/j.cellimm.2006.08.003. Epub 2006 Sep 27. Cell Immunol. 2006. PMID: 17010326

3

Addition of an extra immunoglobulin domain to two anti-rodent TNF monoclonal antibodies substantially increased their potency.

Scallon B, Cai A, Radewonuk J, Naso M. Scallon B, et al. Among authors: radewonuk j. Mol Immunol. 2004 May;41(1):73-80. doi: 10.1016/j.molimm.2004.01.006. Mol Immunol. 2004. PMID: 15140577

4

Quantitative in vivo comparisons of the Fc gamma receptor-dependent agonist activities of different fucosylation variants of an immunoglobulin G antibody.

Scallon B, McCarthy S, Radewonuk J, Cai A, Naso M, Raju TS, Capocasale R. Scallon B, et al. Among authors: radewonuk j. Int Immunopharmacol. 2007 Jun;7(6):761-72. doi: 10.1016/j.intimp.2007.01.014. Epub 2007 Feb 15. Int Immunopharmacol. 2007. PMID: 17466910

5

Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials.

Sheehan DV, Gasior M, McElroy SL, Radewonuk J, Herman BK, Hudson J. Sheehan DV, et al. Among authors: radewonuk j. Innov Clin Neurosci. 2018 Jun 1;15(5-6):22-29. Innov Clin Neurosci. 2018. PMID: 30013816 Free PMC article.

6

Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial.

Hudson JI, McElroy SL, Ferreira-Cornwell MC, Radewonuk J, Gasior M. Hudson JI, et al. Among authors: radewonuk j. JAMA Psychiatry. 2017 Sep 1;74(9):903-910. doi: 10.1001/jamapsychiatry.2017.1889. JAMA Psychiatry. 2017. PMID: 28700805 Free PMC article. Clinical Trial.

7

Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder.

McElroy SL, Hudson JI, Gasior M, Herman BK, Radewonuk J, Wilfley D, Busner J. McElroy SL, et al. Among authors: radewonuk j. Int J Eat Disord. 2017 Aug;50(8):884-892. doi: 10.1002/eat.22722. Epub 2017 May 8. Int J Eat Disord. 2017. PMID: 28481434 Free PMC article. Clinical Trial.

8

A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder.

Gasior M, Hudson J, Quintero J, Ferreira-Cornwell MC, Radewonuk J, McElroy SL. Gasior M, et al. Among authors: radewonuk j. J Clin Psychopharmacol. 2017 Jun;37(3):315-322. doi: 10.1097/JCP.0000000000000702. J Clin Psychopharmacol. 2017. PMID: 28383364 Free PMC article. Clinical Trial.

9

Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials.

McElroy SL, Hudson J, Ferreira-Cornwell MC, Radewonuk J, Whitaker T, Gasior M. McElroy SL, et al. Among authors: radewonuk j. Neuropsychopharmacology. 2016 Apr;41(5):1251-60. doi: 10.1038/npp.2015.275. Epub 2015 Sep 9. Neuropsychopharmacology. 2016. PMID: 26346638 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters